Sfoglia per Autore
Laparoscopic aspiration of ovarian endometriomas : effect with postoperative gonadotropin releasing hormone agonist treatment
1992 P. Vercellini, N. Vendola, L. Bocciolone, A. Colombo, M.T. Rognoni, G. Bolis
Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomas
1993 P. Vercellini, L. Bocciolone, A. Colombo, N. Vendola, M. Meschia, G. Bolis
Endometriosis and ovarian cancer
1993 P. Vercellini, F. Parazzini, G. Bolis, S. Carinelli, M. Dindelli, N. Vendola, L. Luchini, P. G. Crosignani
Multifocal endometriosis. A case report
1993 P. Vercellini, N. Vendola, M. Presti, G. Bolis
Survival of advanced ovarian cancer patients with microscopic partial response after surgery and first-line chemotherapy
1995 G. Bolis, A. Villa, C. Ferraris, L. Luchini, F. Parazzini
Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy
1996 G. Bolis, A. Villa, P. Guarnerio, C. Ferraris, N. Gavoni, G. Giardina, M. Melpignano, G. Scarfone, F. Zanaboni, F. Parazzini
Regarding a series of IB bulky cervical cancer treated with neoadjuvant chemotherapy (NACT) and radical hysterectomy and pelvic lymphadenectomy
1996 G. Bolis, A. Villa, P. Guarnerio, S. Acerboni, F. Parazzini
Determinants of response to a cisplatin-based regimen as neoadjuvant chemotherapy in stage IB-IIB invasive cervical cancer
1996 G. Bolis, I. van Zainten Przybysz, G. Scarfone, F. Zanaboni, C. Scarabelli, S. Tateo, M. Calabrese, F. Parazzini
Is abdomino-pelvic radiation therapy the optimal treatment for completely resected stage I and II high risk ovarian cancer?
1997 A. Fyles, G. Bolis, C. Ferraris, F. Parazzini, M. Bolla
A phase I-II trial of fixed-dose carboplatin and escalating paclitaxel in advanced ovarian cancer
1997 G. Bolis, G. Scarfone, F. Zanaboni, A. Villa, M. Presti, M. Melpignano, C. Ferraris, S. Tateo, P. Guarnerio, A. Gentile, F. Parazzini
Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancer
1997 G. Bolis, G. Favalli, S. Danese, F. Zanaboni, G. Mangili, C. Scarabelli, S. Tateo, M. G. Valsecchi, G. Scarfone, G. Richiardi, L. Frigerio, M. Melpignano, A. Villa, F. Parazzini
Case-control study of oestrogen replacement therapy and risk of cervical cancer
1997 F. Parazzini, C. La Vecchia, E. Negri, S. Franceschi, S. Moroni, L. Chatenoud, G. Bolis
Ovarian cancer risk and history of selected medical conditions linked with female hormones
1997 F. Parazzini, S. Moroni, C. La Vecchia, E. Negri, D. dal Pino, G. Bolis
Survival and prognostic factors of early ovarian cancer
1998 A. Villa, F. Parazzini, S. Acerboni, P. Guarnerio, G. Bolis
The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol
1998 R. Silvestrini, M.G. Daidone, S. Veneroni, E. Benini, G. Scarfone, F. Zanaboni, A. Villa, M. Presti, S. Danese, G. Bolis
Determinants of risk of invasive cervical cancer in young women
1998 F. Parazzini, L. Chatenoud, C. La Vecchia, E. Negri, S. Franceschi, G. Bolis
Topotecan for the treatment of advanced epithelial ovarian cancer : An open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel
1998 M.A. Bookman, H. Malmström, G. Bolis, A. Gordon, A. Lissoni, J.B. Krebs, S.Z. Fields
Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group
1998 K. Aabo, M. Adams, P. Adnitt, D.S. Alberts, A. Athanazziou, V. Barley, D.R. Bell, U. Bianchi, G. Bolis, M.F. Brady, H.S. Brodovsky, H. Bruckner, M. Buyse, R. Canetta, V. Chylak, C.J. Cohen, N. Colombo, P.F. Conte, D. Crowther, J.H. Edmonson, C. Gennatas, E. Gilbey, M. Gore, D. Guthrie, B.Y. Yeap
A phase I-II trial of high-dose ifosfamide in patients with ovarian cancer refractory or resistant to platinum and/or paclitaxel-containing chemotherapy
1999 G. Scarfone, A. Villa, F. Parazzini, C. Sciatta, G. Polverino, G. Bolis
Survival and determinants of response to third-line chemotherapy in sensitive recurrent ovarian cancer patients
1999 A. Villa, F. Parazzini, G. Scarfone, P. Guarnerio, G. Bolis
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile